Home > Products > CD44 & CR3
> Recombinant Anti-CD44 x Anti-CR3 Bispecific Antibody (scIgG)
Recombinant Anti-CD44 x Anti-CR3 Bispecific Antibody (scIgG) (CAT#: SCIGG-121)
Recombinant Anti-CD44 x Anti-CR3 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD44 and anti-CR3 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can recruit macrophages to tumor cells. It is designed for the research of Glioblastoma; Squamous cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD44 x Anti-CR3 Bispecific Antibody (scIgG) (SCIGG-121). Click the button below to contact us or submit your feedback about this product.